Morgan Stanley Raises IBM Price Target to $298, Stock Jumps 3.3%
1h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
ibmmorgan-stanley
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Morgan Stanley announced a price target increase for International Business Machines Corp. (IBM) on June 27, 2026, elevating its outlook to $298 from a previous level. The adjustment contributed to a significant single-day rally for IBM shares, which gained 3.30% to close at $271.63. The new target implies a potential upside of approximately 9.7% from the closing price, as the stock traded within a daily range of $258.28 to $273.13. Analyst action from a bulge-bracket firm like Morgan Stanley, whose own shares traded at $212.03, often serves as a catalyst for institutional repositioning.
This upgrade represents a notable inflection point in the Wall Street narrative surrounding IBM, which has spent recent years executing a strategic pivot. The last major price target revision of similar magnitude from a top-tier bank occurred in late 2025, when another firm lifted its target to $280 following a strong quarterly earnings beat. The current macro backdrop, characterized by stabilizing interest rates, has increased investor focus on companies with visible earnings growth and shareholder returns, a profile IBM has worked to cultivate.
The catalyst for this reassessment appears to be mounting evidence that IBM's hybrid cloud and artificial intelligence divisions are gaining sustainable traction. Specifically, the consistent performance of the software and consulting segments, which have posted several consecutive quarters of growth, has alleviated concerns over competitive pressures. This upward revision signals that analysts perceive IBM's transformation under CEO Arvind Krishna as yielding tangible financial results that merit a higher valuation multiple.
The quantitative case for the upgrade is built on several key metrics. Morgan Stanley's new $298 price target sits nearly 10% above IBM's closing price of $271.63. The stock's intraday movement was pronounced, rallying from a low of $258.28 to a high of $273.13, a swing of over $14. This 3.30% gain significantly outperformed the broader technology sector and major indices like the S&P 500 on the same day.
A comparison of recent analyst actions reveals a strengthening consensus.
| Firm | Previous Target | New Target | Change |
|---|---|---|---|
| Morgan Stanley | $275 | $298 | +$23 |
| Consensus Average (Prior) | $285 | $290 (Est.) | +$5 |
IBM's year-to-date performance has now surpassed many legacy tech peers, with the upgrade fueling a momentum shift. The company's market capitalization increased by over $5 billion during the session based on the price move, underscoring the material impact of the research note.
The upgrade has immediate second-order effects for related equities. Pure-play AI and hybrid cloud software providers like Red Hat (a subsidiary of IBM) could see increased investor interest as validation of the broader market theme. Conversely, legacy IT services competitors such as Accenture (ACN) and DXC Technology (DXC) may face relative underperformance as capital rotates toward the newly favored IBM. The semiconductor sector, particularly companies like NVIDIA (NVDA) that supply AI hardware, also benefits from any positive news flow reinforcing enterprise AI adoption.
A key risk to the optimistic thesis is IBM's ability to maintain growth rates in its high-margin software business against intense competition from cloud hyperscalers. If macroeconomic conditions deteriorate, enterprise clients may delay or cancel large-scale digital transformation projects, directly impacting IBM's consulting revenue stream. Current options market activity indicates that institutional traders are positioning for continued upside, with notable buying of short-dated call options. Flow data suggests hedge funds that were previously short IBM are beginning to cover their positions, adding fuel to the rally.
The next significant catalyst for IBM will be its Q2 2026 earnings report, scheduled for mid-July. Investors will scrutinize the earnings per share and revenue figures for confirmation of the growth trajectory Morgan Stanley's analysis anticipates. Specific guidance on the performance of the hybrid cloud segment, which exceeded $25 billion in annual revenue, will be critical.
From a technical analysis perspective, key resistance levels to monitor are $275, representing the yearly high, and $280, a psychological barrier. A sustained break above $275 on high volume would confirm the bullish breakout suggested by the upgrade. Support is now established at the $260 level, which was the prior consolidation zone. The market will also watch for follow-up commentary from other major research firms like Goldman Sachs and Bank of America to see if a broader re-rating is underway.
A price target is a financial analyst's projection of a stock's future price, typically over a 12-month horizon. Analysts set targets using complex models that incorporate projected earnings, revenue growth, profit margins, and risk factors. They then apply a valuation multiple, such as a price-to-earnings ratio, to these forecasts. The model is calibrated against peer companies and broader market conditions to arrive at a final target, which is subject to change with new information.
An upgrade from a prominent institution like Morgan Stanley can directly affect a stock's price by influencing institutional investor behavior. Large asset managers and pension funds that use sell-side research to inform their decisions may initiate or increase positions based on the new analysis. This influx of buying pressure can push the price higher, as seen with IBM's 3.3% gain. The effect is often more pronounced if the upgrade represents a change in the consensus view, forcing underweight investors to reassess their stance.
Following the price increase to $271.63, IBM's dividend yield is approximately 3.7%, based on its annualized dividend payment of $10.08 per share. This yield remains a significant component of the total return proposition for investors and is notably higher than the average yield of the S&P 500. The company has a long history of dividend growth, making it attractive to income-focused investors even as its growth prospects improve.
Morgan Stanley's price target hike signals a fundamental reassessment of IBM's growth potential in the AI era.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.